ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 972–979
DOI: 10.46882/AJIDR/149039
Article Type: Research Article
Title: Seroprevalence and molecular epidemiology of hepatitis D virus co-infection among chronic hepatitis B surface antigen carriers
Names of Authors: Nadia Benali-Mansour¹*, Lukas Novak², Samuel Boateng-Mensah³
Abstract: Hepatitis D virus is a defective satellite RNA virus requiring hepatitis B surface antigen for assembly, accelerating progression to liver cirrhosis and hepatocellular carcinoma. We determined anti-hepatitis D antibody prevalence, viral RNA viremia, and genotype distribution among chronic hepatitis B outpatients. Serum samples from 410 surface antigen-positive adults were screened via competitive enzyme-linked immunosorbent assay and reverse transcription quantitative polymerase chain reaction. Anti-hepatitis D seropositivity reached 12.4 percent, with genotype 1 strains predominating among viremic patients exhibiting advanced hepatic fibrosis. Universal hepatitis B immunization and reflex delta screening curb severe liver disease.
Keywords: Hepatitis D virus, Hepatitis B co-infection, Hepatic fibrosis, Viral genotypes, Chronic viral hepatitis
Citation: Benali-Mansour N, Novak L, Boateng-Mensah S (2026). Seroprevalence and molecular epidemiology of hepatitis D virus co-infection among chronic hepatitis B surface antigen carriers. African Journal of Infectious Diseases Research, 13(11): 972–979. DOI: 10.46882/AJIDR/149039
Manuscript Timeline: Received: October 14, 2026; Revised: November 13, 2026; Accepted: November 27, 2026; Published: November 30, 2026
African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 964–971
DOI: 10.46882/AJIDR/149038
Article Type: Research Article
Title: Antimicrobial resistance determinants and virulence plasmid carriage in Klebsiella aerogenes nosocomial bloodstream infections
Names of Authors: Yusuf Al-Jamil¹*, Klara Lindqvist², Diego Morales-Reyes³
Abstract: Klebsiella aerogenes is an opportunistic Enterobacterales pathogen capable of developing rapid derepressed AmpC beta-lactamase resistance during third-generation cephalosporin therapy. We evaluated inducible AmpC hyperproduction, carbapenemase genes, and clinical mortality predictors among bacteremic inpatients. Non-duplicate bloodstream isolates from 104 hospitalized adults underwent broth microdilution, whole-genome sequencing, and clinical chart review. Resistance to ceftriaxone and cefepime was observed in 48.1 percent and 17.3 percent of isolates respectively, whereas meropenem and amikacin retained over 94.0 percent activity. Avoiding third-generation cephalosporins for invasive infections prevents treatment failure.
Keywords: Klebsiella aerogenes, AmpC beta-lactamase, Nosocomial bacteremia, Antimicrobial resistance, Enterobacterales
Citation: Al-Jamil Y, Lindqvist K, Morales-Reyes D (2026). Antimicrobial resistance determinants and virulence plasmid carriage in Klebsiella aerogenes nosocomial bloodstream infections. African Journal of Infectious Diseases Research, 13(11): 964–971. DOI: 10.46882/AJIDR/149038
Manuscript Timeline: Received: October 13, 2026; Revised: November 12, 2026; Accepted: November 27, 2026; Published: November 30, 2026
African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 956–963
DOI: 10.46882/AJIDR/149037
Article Type: Research Article
Title: Prevalence, genotype diversity, and antiviral susceptibility of human metapneumovirus in hospitalized older adults with acute respiratory distress
Names of Authors: Sophie Laurent-Dubois¹*, Chukwuemeka Eze², Haruto Takahashi³
Abstract: Human metapneumovirus causes substantial seasonal morbidity and hypoxic respiratory failure in older adults and individuals with chronic cardiopulmonary comorbidities. We characterized fusion gene subgroups, viral co-infection rates, and intensive care admission predictors among hospitalized seniors. Nasopharyngeal swabs from 330 adults aged 65 years and older were tested via multiplex reverse transcription polymerase chain reaction and phylogenetic sequencing. Subgroups A2b and B1 accounted for 71.5 percent of confirmed cases, with secondary bacterial pneumonia occurring in 24.8 percent of patients. Routine multiplex viral testing reduces unnecessary antibiotic exposure.
Keywords: Human metapneumovirus, Geriatric respiratory infection, Viral pneumonia, Phylogenetic analysis, Respiratory viruses
Citation: Laurent-Dubois S, Eze C, Takahashi H (2026). Prevalence, genotype diversity, and antiviral susceptibility of human metapneumovirus in hospitalized older adults with acute respiratory distress. African Journal of Infectious Diseases Research, 13(11): 956–963. DOI: 10.46882/AJIDR/149037
Manuscript Timeline: Received: October 12, 2026; Revised: November 11, 2026; Accepted: November 26, 2026; Published: November 30, 2026
African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 948–955
DOI: 10.46882/AJIDR/149036
Article Type: Research Article
Title: Molecular surveillance and fexinidazole treatment outcomes in second-stage Trypanosoma brucei gambiense human African trypanosomiasis
Names of Authors: Jean-Paul Kabongo¹*, Astrid Lindberg², Rajesh Nair³
Abstract: Gambiense human African trypanosomiasis is a fatal vector-borne protozoan disease targeting the central nervous system if left untreated during the hemolymphatic stage. We assessed diagnostic sensitivity of loop-mediated isothermal amplification, cerebrospinal fluid white cell counts, and oral fexinidazole cure rates. Blood and cerebrospinal fluid specimens from 94 seropositive patients were examined at baseline and 12 months post-treatment. Oral fexinidazole achieved a 92.6 percent treatment success rate in late-stage disease without requiring routine lumbar puncture in non-severe presentations. All-oral therapy accelerates sleeping sickness elimination.
Keywords: Trypanosoma brucei gambiense, African trypanosomiasis, Fexinidazole, Neglected tropical diseases, Protozoan infections
Citation: Kabongo J, Lindberg A, Nair R (2026). Molecular surveillance and fexinidazole treatment outcomes in second-stage Trypanosoma brucei gambiense human African trypanosomiasis. African Journal of Infectious Diseases Research, 13(11): 948–955. DOI: 10.46882/AJIDR/149036
Manuscript Timeline: Received: October 11, 2026; Revised: November 10, 2026; Accepted: November 26, 2026; Published: November 30, 2026
African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 940–947
DOI: 10.46882/AJIDR/149035
Article Type: Research Article
Title: Serotype distribution and beta-lactamase resistance profiles of Haemophilus influenzae in pediatric community-acquired pneumonia
Names of Authors: Katarina Horvat¹*, Kwabena Osei², Min-Jae Kim³
Abstract: Haemophilus influenzae remains a major respiratory pathogen in young children, with non-typeable strains increasingly implicated in invasive and mucosal infections following Hib vaccination. We determined capsular genotypes, blaTEM-1 carriage, and penicillin-binding protein 3 mutations among pediatric respiratory isolates. Induced sputum and blood cultures from 265 hospitalized children were evaluated via slide agglutination, multiplex polymerase chain reaction, and broth microdilution. Non-typeable Haemophilus influenzae accounted for 83.4 percent of isolates, with beta-lactamase-negative ampicillin-resistant strains representing 16.2 percent. Amoxicillin-clavulanate and third-generation cephalosporins remain reliable empirical therapies.
Keywords: Haemophilus influenzae, Pediatric pneumonia, Beta-lactamase resistance, Non-typeable strains, Respiratory pathogens
Citation: Horvat K, Osei K, Kim M (2026). Serotype distribution and beta-lactamase resistance profiles of Haemophilus influenzae in pediatric community-acquired pneumonia. African Journal of Infectious Diseases Research, 13(11): 940–947. DOI: 10.46882/AJIDR/149035
Manuscript Timeline: Received: October 10, 2026; Revised: November 09, 2026; Accepted: November 25, 2026; Published: November 30, 2026
African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 932–939
DOI: 10.46882/AJIDR/149034
Article Type: Research Article
Title: Genomic characterization and clinical manifestations of Toxoplasma gondii ocular retinochoroiditis in immunocompetent adults
Names of Authors: Adesola Adeyemi¹*, Henrik Lindstrom², Camila Delgado³
Abstract: Ocular toxoplasmosis is a leading infectious cause of posterior uveitis and irreversible visual impairment in both congenital and postnatally acquired infections. We investigated parasite multilocus genotypes, aqueous humor viral-parasitic co-infections, and visual acuity outcomes among patients with active retinochoroiditis. Aqueous humor aspirates and serum samples from 82 patients were analyzed via B1 gene quantitative polymerase chain reaction and restriction fragment length polymorphism typing. Atypical recombinant genotypes predominated in 54.9 percent of intraocular samples and correlated with severe vitritis. Prompt trimethoprim-sulfamethoxazole and corticosteroid therapy preserves retinal function.
Keywords: Toxoplasma gondii, Ocular toxoplasmosis, Retinochoroiditis, Posterior uveitis, Molecular genotyping
Citation: Adeyemi A, Lindstrom H, Delgado C (2026). Genomic characterization and clinical manifestations of Toxoplasma gondii ocular retinochoroiditis in immunocompetent adults. African Journal of Infectious Diseases Research, 13(11): 932–939. DOI: 10.46882/AJIDR/149034
Manuscript Timeline: Received: October 09, 2026; Revised: November 08, 2026; Accepted: November 25, 2026; Published: November 30, 2026